In the News

413 News Items found
Scott Lowe
MSK researchers and collaborators have developed a new type of CAR T cell designed to attack a cell surface protein called uPAR — allowing them to target both tumors and cancer-supporting cells in the tumor microenvironment.
NBC’s Today Show Spotlights MSK and Addresses Access to Care at Comprehensive Cancer Centers
On July 22, 2021, Memorial Sloan Kettering Cancer Center was prominently featured on NBC News/The Today Show about “How to Navigate Nation’s Top Hospitals.”
photo of sample blood vials
Finding
A sensitive assay for detecting tumor DNA in the blood performed well in patients and may herald the development of a blood test for cancer screening.
Petri dish with green mold on it
Science Byte
Learn how immune cells in the lungs trigger invasive fungal cells to self-destruct. The discovery could produce therapies to prevent infection in cancer patients.
Five MSK researcher headshots
Read about the latest findings in immunotherapy from the 2021 annual meeting of the American Society of Clinical Oncology (ASCO).
Dr. Santosha Vardhana
During the AACR COVID-19 and Cancer Meeting, several MSK physicians presented information about providing safe patient care, vaccines, and clinical research.
Ingo Mellinghoff, Chair of the Department of Neurology at Memorial Sloan Kettering
Ingo Mellinghoff is optimistic about the future of brain cancer treatments as the new Chair of MSK’s Department of Neurology.
A new analysis of survival data for the randomized, phase III PACIFIC trial finds adding the immunotherapy cancer drug durvalumab to radiation and chemotherapy significantly decreased the recurrence of lung cancer both in the chest area and in distant sites outside the chest. The updated PACIFIC trial data will be presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), by Andreas Rimner, MD, radiation oncologist, Memorial Sloan Kettering Cancer Center.
Woman waving a pom pom at the Cycle for Survival event at MetLife Stadium
Every day, your commitment to funding life-changing cancer research at Memorial Sloan Kettering is ensuring a brighter future for people with cancer around the world. Thank you for your continued support.
micrograph of a T cell
A team of researchers from MSK has developed a new type of CAR T cell therapy that shows promise against acute myeloid leukemia (AML) in preclinical models.